The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
In a letter to the editor, recommendations are presented regarding anesthesia procedures for emergency operations in patients with suspected or confirmed coronavirus 2019.
A study of Chinese healthcare workers may foreshadow the mental health burden placed upon physicians, nurses, and other professionals as COVID-19 strains the medical system in the United States.
The American Heart Association released interim guidance on resuscitation care in patients with known or suspected COVID-19.
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.
There is currently no evidence that SARS-CoV-2 undergoes intrauterine or transplacental transmission from COVID-19-infected pregnant women to fetuses.
The Centers for Disease Control and Prevention (CDC) released preliminary data related to outcomes among US patients with coronavirus disease 2019 (COVID-19).
Current mortality rate estimates for COVID-19 may not be representative of the actual death rate.
The policy is intended to remain in effect only for the duration of the COVID-19 public health emergency declared by the Department of Health and Human Services (HHS).
The effect of COVID-19 response in China shows that quarantine, social distancing, and isolation of infected persons can contain the epidemic in other countries.
